# Administration of CBG000592 (Riboflavin/Vitamin B2) in Patients With Acute Ischemic Stroke

> **NCT02446977** · PHASE2 · COMPLETED · sponsor: **Castillo, José, M.D.** · enrollment: 50 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Vitamin B2 Streuli®
- **OTHER:** Solution for injection

## Key facts

- **NCT ID:** NCT02446977
- **Lead sponsor:** Castillo, José, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02446977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02446977, "Administration of CBG000592 (Riboflavin/Vitamin B2) in Patients With Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02446977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*